Mylan Pharmaceuticals Private Limited Bevacizumab Export Data — India (DGFT 2022–2026)

Name: Mylan Pharmaceuticals Private Limited Bevacizumab Export Records India — #7 Exporter, 13 Shipments, $650.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bevacizumab

India Pharmaceutical Trade Intelligence

$46.9M196 Suppliers100 CountriesHS 30021500

ExportsIndia → RUSSIA50.3%India → NETHERLANDS14.3%

ImportsSWITZERLAND → India$1.2B GERMANY → India$344.1M

#1 Buyer: JSC R-PHARM

Mylan Pharmaceuticals Private Limited — Bevacizumab Exporter #7 | $650.0K Trade Value | TransData Nexus | TransData Nexus

Mylan Pharmaceuticals Private Limited — Bevacizumab Exporter Profile

Indian Pharmaceutical Exporter · #7 for Bevacizumab · $650.0K export value · DGFT Verified

Mylan Pharmaceuticals Private Limited is the #7 Indian exporter of Bevacizumab with $650.0K in export value and 13 verified shipments. Mylan Pharmaceuticals Private Limited holds a 1.4% market share in Bevacizumab exports across 5 countries. The company exports 2 pharmaceutical products worth $900.0K across 1 therapeutic categories.

Mylan Pharmaceuticals Private Limited — Bevacizumab Export Profile: Buyers & Destinations

Mylan Pharmaceuticals Private Limited Bevacizumab export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Pharmaceuticals Private Limited Export Bevacizumab?

Country	Value	Shipments	Share
MOLDOVA,REPUBLIC OF	$112.4K	4	33.5%
ZIMBABWE	$90.0K	4	26.8%
KENYA	$83.0K	2	24.8%
GAUTEMALA	$50.0K	1	14.9%
BANGLADESH	$0	2

Who Are the Top Buyers of Bevacizumab from Mylan Pharmaceuticals Private Limited?

Buyer	Country	Value	Orders
DITA ESTFARM SRL	MOLDOVA,REPUBLIC OF	$112.4K	4
NEW AVAKASH INTERNATIONAL	ZIMBABWE	$90.0K	4
M/S. SURGILINKS LIMITED.,	KENYA	$83.0K	2
M/S. AVIV FARMACEUTICA S.A.,	GAUTEMALA	$50.0K	1
CONTACT PERSON:LUTFUR RAHMAN,	BANGLADESH	$0	2

Mylan Pharmaceuticals Private Limited supplies Bevacizumab to 5 buyers globally. The largest buyer is DITA ESTFARM SRL (MOLDOVA,REPUBLIC OF), followed by NEW AVAKASH INTERNATIONAL (ZIMBABWE) and M/S. SURGILINKS LIMITED., (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Bevacizumab Formulations Does Mylan Pharmaceuticals Private Limited Export?

Product Description / Formulation	Value	Shipments
BEVACIZUMAB CSI 400MG/16ML 1 VL IN MY	$150.0K	3
BEVACIZUMAB CSI 100MG/4ML 1 VL IN MY	$95.4K	4
BEVACIZUMAB CSI 400MG 16ML 1 VL IN MY	$70.0K	2
BEVACIZUMAB CSI 100MG 4ML 1 VL IN MY	$20.0K	2
(ABEVMY 400 MG(BEVACIZUMAB INJECTION(R-D	$0	1
(ABEVMY 100 MG(BEVACIZUMAB INJECTION(R-D	$0	1

Mylan Pharmaceuticals Private Limited exports 6 distinct Bevacizumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BEVACIZUMAB CSI 400MG/16ML 1 VL IN MY with 3 shipments worth $150.0K.

How Does Mylan Pharmaceuticals Private Limited Compare to Nearest Bevacizumab Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	ZYDUS LIFESCIENCES LIMITED	$1.1M	21	4	$50.0K
3	DR REDDY S LABORATORIES LTD	$700.0K	14	1	$50.0K
7	MYLAN PHARMACEUTICALS PRIVATE LIMITED ★	$650.0K	13	5	$50.0K
6	DR REDDYS LABORATORIES LIMITED	$500.0K	10	4	$50.0K
8	DR.REDDY'S LABORATORIES LIMITED	$500.0K	10	4	$50.0K

Mylan Pharmaceuticals Private Limited ranks #7 among 196 Indian Bevacizumab exporters. Average shipment value of $50.0K compared to the market average of $77.5K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and DR REDDY S LABORATORIES LTD.

Which Indian Ports Ship Bevacizumab Exports?

Port	Shipments	% Share
SAHAR AIR	345	24.5%
SAHAR AIR CARGO ACC (INBOM4)	327	23.2%
HYDERABAD ACC (INHYD4)	132	9.4%
Bombay Air	89	6.3%
DELHI AIR CARGO ACC (INDEL4)	48	3.4%
DELHI AIR	47	3.3%
HYDERABAD AIR	36	2.6%
AHEMDABAD AIR	32	2.3%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bevacizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 13 individual customs records matching Mylan Pharmaceuticals Private Limited exporting Bevacizumab, covering 6 formulations to 5 countries via 5 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 346+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bevacizumab

Bevacizumab

Mylan Pharmaceuticals Private Limited — Bevacizumab Exporter Profile

Mylan Pharmaceuticals Private Limited — Bevacizumab Export Profile: Buyers & Destinations

Where Does Mylan Pharmaceuticals Private Limited Export Bevacizumab?

Who Are the Top Buyers of Bevacizumab from Mylan Pharmaceuticals Private Limited?

What Is India's Total Bevacizumab Export Value and How Much Does Mylan Pharmaceuticals Private Limited Contribute?

What Is the Average Shipment Value for Mylan Pharmaceuticals Private Limited's Bevacizumab Exports?

How Does Mylan Pharmaceuticals Private Limited Compare to Other Indian Bevacizumab Exporters?

What Bevacizumab Formulations Does Mylan Pharmaceuticals Private Limited Export?

How Does Mylan Pharmaceuticals Private Limited Compare to Nearest Bevacizumab Exporters?

Which Indian Ports Ship Bevacizumab Exports?

What Other Advanced Oncology Products Does Mylan Pharmaceuticals Private Limited Export?

About Mylan Pharmaceuticals Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bevacizumab Export Data from Mylan Pharmaceuticals Private Limited

Bevacizumab Stats

Company Overview

Top Products by Mylan Pharmaceuticals Private Limited

Related Analysis

Need Detailed Export Data?

Data Source